Xylem Inc (XYL) is a publicly traded specialty industrial machinery business based in the US. In the week up to 25 January Xylem shares plunged 9.69% to a closing position of $102.54. However, over the last 12 months, Xylem's share price has risen by 29.45% from $89.46. Xylem is listed on the NYSE and employs 17,000 staff. All prices are listed in US Dollars.
Best for
0% commission
Best for
Beginner investments
Best for
Beginners
Best for
Mobile app
Both exchange rates and share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.
| Platform | Platform fee | Min. initial deposit | Trading fee estimate | |
|---|---|---|---|---|
|
£0 | $50 | £2.40 £482.84 total |
Capital at risk |
|
£0 | £250 | £10.74 £491.18 total |
Capital at risk |
|
£0 | £1 | £2.16 £482.60 total |
Capital at risk |
|
£0 | No minimum | £4.80 £485.24 total |
Capital at risk |
 |
£0 | £1 | £16.75 £497.19 total |
Capital at risk |
 |
£0 | £0.01 | £0.48 £480.92 total |
Capital at risk |
 |
£9.99 per month | No minimum | £15.20 £495.63 total |
Capital at risk |
 |
£36 per year | £20 | £15.51 £495.94 total |
Capital at risk |
 |
£0 | £50 | £2.40 £482.84 total |
Capital at risk |
Full comparison of share dealing platforms
Historical closes compared with the last close of $115.81
| 1 week (2023-02-01) | 10.38% |
|---|---|
| 1 month (2023-01-06) | 4.08% |
| 3 months (2022-11-08) | 6.96% |
| 6 months (2022-08-08) | 16.21% |
| 1 year (2022-02-04) | 27.95% |
|---|---|
| 2 years (2021-02-08) | 14.71% |
| 3 years (2020-02-07) | 37.54% |
| 5 years (2018-02-07) | 61.32% |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value.
Xylem's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 60x. In other words, Xylem shares trade at around 60x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Xylem's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.6436. Higher PEG ratios such as this can be interpreted as meaning the shares offer worse value given the current rate of growth.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Xylem's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Xylem's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $814 million (£0.0 million).
The EBITDA is a measure of a Xylem's overall financial performance and is widely used to measure a its profitability.
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Xylem.
Xylem's total ESG risk: 17.42
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Xylem's overall score of 17.42 (as at 01/01/2019) is excellent – landing it in it in the 11st percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Xylem is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Xylem's environmental score: 4.03/100
Xylem's environmental score of 4.03 puts it squarely in the 2nd percentile of companies rated in the same sector. This could suggest that Xylem is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Xylem's social score: 5.78/100
Xylem's social score of 5.78 puts it squarely in the 2nd percentile of companies rated in the same sector. This could suggest that Xylem is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Xylem's governance score: 6.61/100
Xylem's governance score puts it squarely in the 2nd percentile of companies rated in the same sector. That could suggest that Xylem is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Xylem's controversy score: 2/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. A high-profile company, Xylem scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Xylem has, for the most part, managed to keep its nose clean.
Xylem Inc was last rated for ESG on: 2019-01-01.
| Total ESG score | 17.42 |
|---|---|
| Total ESG percentile | 11.14 |
| Environmental score | 4.03 |
| Environmental score percentile | 2 |
| Social score | 5.78 |
| Social score percentile | 2 |
| Governance score | 6.61 |
| Governance score percentile | 2 |
| Level of controversy | 2 |
| Open | $118.2 |
|---|---|
| High | $118.9402 |
| Low | $115.55 |
| Close | $115.81 |
| Previous close | $118.64 |
| Change | $-2.83 |
| Change % | -2.3854% |
| Volume | 1,503,933 |
| 52-week range | $71.6519 - $118.58 |
|---|---|
| 50-day moving average | $110.5828 |
| 200-day moving average | $94.6124 |
| Wall St. target price | $114.9 |
| PE ratio | 59.7759 |
| Dividend yield | $1.18 (1.17%) |
| Earnings per share (TTM) | $1.74 |
Dividend yield: 1.17% of stock value
Forward annual dividend yield: 1.17% of stock value
Dividend payout ratio: 62.5% of net profits
Xylem has recently paid out dividends equivalent to 1.17% of its share value annually.
Xylem has paid out, on average, around 62.5% of recent net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.17% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), shareholders could enjoy a 1.17% return on their shares, in the form of dividend payments. In Xylem's case, that would currently equate to about $1.18 per share.
Xylem's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
Xylem's most recent dividend payout was on 20 December 2022. The latest dividend was paid out to all shareholders who bought their shares by 21 November 2022 (the "ex-dividend date").
Over the last 12 months, Xylem's shares have ranged in value from as little as $71.6519 up to $118.58. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Xylem's is 1.0921. This would suggest that Xylem's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Ever wondered how to buy shares in STAG Industrial? We explain how and compare a range of providers that can give you access to many brands, including STAG Industrial.
Ever wondered how to buy shares in Camtek? We explain how and compare a range of providers that can give you access to many brands, including Camtek.
Ever wondered how to buy shares in Axalta Coating Systems? We explain how and compare a range of providers that can give you access to many brands, including Axalta Coating Systems.
Ever wondered how to buy shares in The Eastern Company? We explain how and compare a range of providers that can give you access to many brands, including The Eastern Company.
Ever wondered how to buy shares in Ultralife? We explain how and compare a range of providers that can give you access to many brands, including Ultralife.
Ever wondered how to buy shares in Sensient Technologies? We explain how and compare a range of providers that can give you access to many brands, including Sensient Technologies.
Ever wondered how to buy shares in Covanta Holding? We explain how and compare a range of providers that can give you access to many brands, including Covanta Holding.
Ever wondered how to buy shares in Cabot Microelectronics? We explain how and compare a range of providers that can give you access to many brands, including Cabot Microelectronics.
Ever wondered how to buy shares in Broadwind? We explain how and compare a range of providers that can give you access to many brands, including Broadwind.
Ever wondered how to buy shares in Veeco Instruments? We explain how and compare a range of providers that can give you access to many brands, including Veeco Instruments.
